XOMA Royalty (XOMA) Accounts Payables (2010 - 2026)
XOMA Royalty (XOMA) reported Accounts Payables of $3.5 million for Q1 2026, up 52.39% on a YoY basis from $2.3 million in Q1 2025, and up 60.05% sequentially from $2.2 million in Q4 2025.
XOMA Royalty (XOMA) Accounts Payables (2010 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 17 years of Accounts Payables data on file, last reported at $3.5 million in Q1 2026.
- For the quarter ending Q1 2026, Accounts Payables rose 52.39% year-over-year to $3.5 million; the trailing twelve-month figure through Mar 2026 stood at $3.5 million (up 52.39% YoY), and the FY2025 full-year result was $2.2 million, up 109.69% from the prior year.
- Accounts Payables grew to $3.5 million in Q1 2026, from $2.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $3.5 million in Q1 2026 to a low of $437000.0 in Q1 2023.
- A 5-year average of $1.2 million and a median of $1.0 million in 2022 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables tumbled 51.12% in 2022 and jumped 246.68% in 2024, its largest moves.
- Tracing XOMA's Accounts Payables over 5 years: stood at $524000.0 in 2022, then advanced by 24.62% to $653000.0 in 2023, then soared by 61.26% to $1.1 million in 2024, then jumped by 109.69% to $2.2 million in 2025, then soared by 60.05% to $3.5 million in 2026.
- Business Quant data shows XOMA's Accounts Payables at $3.5 million in Q1 2026, $2.2 million in Q4 2025, and $1.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 5.74 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 10.62 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 423.55 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 694,346.76 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 489.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.03 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.52 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 80.54 Mn |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | 3.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.53 Mn |
| Dec 31, 2025 | 2.21 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 982,000.00 |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 653,000.00 |
| Sep 30, 2023 | 728,000.00 |
| Jun 30, 2023 | 740,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 524,000.00 |
| Sep 30, 2022 | 985,000.00 |
| Jun 30, 2022 | 1.15 Mn |
| Mar 31, 2022 | 787,000.00 |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 598,000.00 |
| Jun 30, 2021 | 629,000.00 |
| Mar 31, 2021 | 671,000.00 |